Literature DB >> 12970913

Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.

Yi-Ming Li1, Fan Lv, Xin Xu, Hong Ji, Wen-Tao Gao, Tuan-Jie Lei, Gui-Bing Ren, Zhi-Lan Bai, Qiang Li.   

Abstract

AIM: Our research attempted to evaluate the overall functional reserve of cirrhotic liver by combination of hepatic functional blood flow, liver volume, and Child-Pugh's classification, and to discuss its value of clinical application.
METHODS: Ninety two patients with portal hypertension due to hepatic cirrhosis were investigated. All had a history of haematemesis and hematochezia, esophageal and gastric fundus varices, splenomegaly and hypersplenia. A 2-year follow-up was routinely performed and no one was lost. Twenty two healthy volunteers were used as control group. Blood and urine samples were collected 4 times before and after intravenous D-sorbitol infusion. The hepatic clearance (CL(H)) of D-sorbitol was then calculated according to enzymatic spectrophotometric method while the total blood flow (Q(TOTAL)) and intrahepatic shunt (R(INS)) were detected by multicolor Doppler ultrasound, and the liver volume was measured by spiral CT. Data were estimated by t-test, variance calculation and chi-squared test. The relationships between all these parameters and different groups were investigated according to Child-Pugh classification and postoperative complications respectively.
RESULTS: Steady blood concentration was achieved 120 mins after D-sorbitol intravenous infusion, which was (0.358+/-0.064) mmol x L(-1) in cirrhotic group and (0.189+/-0.05) mmol x L(-1) in control group (P<0.01). CL(H) =(812.7+/-112.4) ml x min(-1), Q(TOTAL) =(1280.6+/-131.4) ml x min(-1), and R(INS) =(36.54+/-10.65) % in cirrhotic group and CL(H)=(1248.3+/-210.5) ml x min(-1), Q(TOTAL)=(1362.4+/-126.9) ml x min(-1), and R(INS)=(8.37+/-3.32) % in control group (P<0.01). The liver volume of cirrhotic group was 1057+/-249 cm(3), 851+/-148 cm(3) and 663+/-77 cm(3) in Child A, B and C group respectively with significant difference (P<0.001). The average volume of cirrhotic liver in Child B, C group was significantly reduced in comparison with that in control group (P<0.001). The patient, whose liver volume decreased by 40 % with the CLH below 600 ml x min(-1), would have a higher incidence of postoperative complications. There was no strict correspondent relationship between CL(H), liver volume and Child-Pugh's classification.
CONCLUSION: The hepatic clearance of D-sorbitol, CT measured liver volume can be reliably used for the evaluation of hepatic functional blood flow and liver metabolic volume. Combined with the Child-Pugh's classification, it could be very useful for further understanding the liver functional reserve, therefore help determine reasonable therapeutic plan, choose surgical procedures and operating time.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970913      PMCID: PMC4656681          DOI: 10.3748/wjg.v9.i9.2092

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Simultaneous measurement of effective hepatic blood flow and systemic circulation.

Authors:  M Hashimoto; G Watanabe
Journal:  Hepatogastroenterology       Date:  2000 Nov-Dec

Review 2.  MELD: the end of Child-Pugh classification?

Authors:  Luigi Pagliaro
Journal:  J Hepatol       Date:  2002-01       Impact factor: 25.083

3.  Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation.

Authors:  Hiroyuki Sugimoto; Tetsuya Kaneko; Soichiro Inoue; Shin Takeda; Akimasa Nakao
Journal:  Hepatogastroenterology       Date:  2002 May-Jun

4.  Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.

Authors:  J Burggraaf; R C Schoemaker; E G Lentjes; A F Cohen
Journal:  Eur J Pharm Sci       Date:  2000-12       Impact factor: 4.384

5.  Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.

Authors:  D G Le Couteur; H Hickey; P J Harvey; J Gready; A J McLean
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

6.  Does the direction of portal blood flow determine outcome with small-diameter prosthetic H-graft portacaval shunt?

Authors:  A S Rosemurgy; J G Norman; S E Goode
Journal:  Surgery       Date:  1997-01       Impact factor: 3.982

7.  Functional significance of hepatic arterial flow reserve in patients with cirrhosis.

Authors:  Alexander Zipprich; Norbert Steudel; Curd Behrmann; Frank Meiss; Ursula Sziegoleit; Wolfgang E Fleig; Gerhard Kleber
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

8.  Sorbitol as a test substance for measurement of liver plasma flow in humans.

Authors:  S Keiding; E Engsted; P Ott
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

9.  Liver volume in patients with or without chronic liver diseases.

Authors:  X Z Lin; Y N Sun; Y H Liu; B S Sheu; B N Cheng; C Y Chen; H M Tsai; C L Shen
Journal:  Hepatogastroenterology       Date:  1998 Jul-Aug

10.  Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

Authors:  Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

View more
  6 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  Assessment of liver volume variation to evaluate liver function.

Authors:  Cong Tong; Xinsen Xu; Chang Liu; Tianzheng Zhang; Kai Qu
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

3.  Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified?

Authors:  Shuang Wei; Xiaoyi Hao; Daqian Zhan; Min Xiong; Kaiyan Li; Xiaoping Chen; Zhiyong Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

4.  A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification.

Authors:  Julie Steelandt; Elodie Jean-Bart; Sylvain Goutelle; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

5.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

6.  The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study.

Authors:  Dao-Bing Zeng; Liang Di; Rui-Chi Zhang; Qing-Liang Guo; Bin-Wei Duan; Cui-Yu Jia; Feng Chen; Dong-Dong Lin; Yun-Jin Zang; Shi-Chun Lu
Journal:  Gastroenterol Res Pract       Date:  2019-04-08       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.